Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Naseer Qayum"'
Autor:
Tycel J. Phillips, Michael Dickinson, Franck Morschhauser, Emmanuel Bachy, Michael Crump, Marek Trněný, Nancy L. Bartlett, Jan Zaucha, Tomasz Wrobel, Fritz Offner, Kathryn Humphrey, Linda Lundberg, James Relf, Audrey Filézac de L'Étang, David Carlile, Ben Byrne, Naseer Qayum, Carmelo Carlo-Stella
Publikováno v:
Blood. 140:178-180
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e448bef1f7643e438bbbab0ca33ed83b
https://doi.org/10.1182/blood-2022-157777
https://doi.org/10.1182/blood-2022-157777
Autor:
Max S. Topp, Monica Tani, Michael Dickinson, Nilanjan Ghosh, Armando Santoro, Antonio Pinto, Francesc Bosch, Christopher P. Fox, Armando López-Guillermo, Claudia Carlucci, Chun Wu, Kathryn Humphrey, Pauline Baumlin, Martin Barrett, Naseer Qayum, Franck Morschhauser
Publikováno v:
Blood. 140:1775-1777
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fa24a12e36e6a17fbd800f77ef8f4ef
https://doi.org/10.1182/blood-2022-157732
https://doi.org/10.1182/blood-2022-157732
Autor:
Adam J. Olszewski, Abraham Avigdor, Sunil Babu, Itai Levi, Herbert Eradat, Uri Abadi, Houston Holmes, Matthew McKinney, Dariusz Woszczyk, Krzysztof Giannopoulos, Wojciech Jurczak, Diana Dunshee, Annie Yang, Mingzhu Zhou, Naseer Qayum, Gila Sellam, Netanel A. Horowitz
Publikováno v:
Blood. 140:1778-1780
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22855896cd4c63b3365f73e4e800d4e0
https://doi.org/10.1182/blood-2022-157768
https://doi.org/10.1182/blood-2022-157768
Autor:
Ruth J. Muschel, W. Gillies McKenna, Eric J. Bernhard, Michael R. Stratford, Jaehong Im, Naseer Qayum
Purpose: Because effective drug delivery is often limited by inadequate vasculature within the tumor, the ability to modulate the tumor microenvironment is one strategy that may achieve better drug distribution. We have previously shown that treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d46a10f476aa647ef157c4c584640b0c
https://doi.org/10.1158/1078-0432.c.6520508.v1
https://doi.org/10.1158/1078-0432.c.6520508.v1
Autor:
Eric J. Bernhard, W. Gillies McKenna, Sonal Patel, Cameron J. Koch, Lukxmi Balathasan, Jae Hong Im, Ruth J. Muschel, Naseer Qayum
Supplementary Figures 1-9 from Tumor Vascular Changes Mediated by Inhibition of Oncogenic Signaling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c3928de8cee22cfe99ec071f4cf0879
https://doi.org/10.1158/0008-5472.22377806
https://doi.org/10.1158/0008-5472.22377806
Autor:
Uri Abadi, Ron McCord, Yuying Xie, Carol O'Hear, Itai Levi, Kati Sarouei, Houston Holmes, Cindy Chen, Abraham Avigdor, Adam J. Olszewski, Sunil Babu, Naseer Qayum, Herbert Eradat, Gila Sellam, Matthew S McKinney
Publikováno v:
Blood. 136:43-45
Introduction: Up to 30% of patients (pts) aged ≥75 years do not receive standard chemoimmunotherapy (CIT) as first-line (1L) treatment for diffuse large B-cell lymphoma (DLBCL) due to concerns about frailty and comorbidities. Poor outcomes are comm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92e375ae924e3befc1050f75fb3e24c7
https://doi.org/10.1182/blood-2020-136255
https://doi.org/10.1182/blood-2020-136255
Autor:
S. Babu, Uri Abadi, Kati Sarouei, Naseer Qayum, Netanel A. Horowitz, Itai Levi, Carol O'Hear, Adam J. Olszewski, Herbert Eradat, Yuying Xie, Krzysztof Giannopoulos, Gila Sellam, Dariusz Woszczyk, Abraham Avigdor, Wojciech Jurczak, Houston Holmes, Ronald McCord, Matthew S McKinney
Publikováno v:
Hematological Oncology. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2abf88ca04b36383e8359f3ad25f2b12
https://doi.org/10.1002/hon.152_2880
https://doi.org/10.1002/hon.152_2880
Autor:
Ron McCord, Adam J. Olszewski, Matthew S McKinney, Dariusz Woszczyk, Gila Sellam, Netanel A. Horowitz, Houston Holmes, Naseer Qayum, Carol O'Hear, Wojciech Jurczak, Itai Levi, Krzysztof Giannopoulos, Herbert Eradat, Abraham Avigdor, Uri Abadi, Yuying Xie, Mingzhu Zhou, Sunil Babu
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S395-S396
Context Mosun, a full-length, humanized, IgG1 CD20×CD3 bispecific antibody, demonstrated efficacy/safety in relapsed/refractory DLBCL (NCT02500407; Schuster, et al. ASH 2019). The phase I/II multicenter GO40554 (NCT03677154) study showed similar res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::501e6013296cbe29e545cc207ebca929
https://doi.org/10.1016/s2152-2650(21)01896-6
https://doi.org/10.1016/s2152-2650(21)01896-6
Autor:
Steven Le Gouill, Naseer Qayum, William Townsend, Max S. Topp, Nilanjan Ghosh, Monica Tani, Armando Santoro, Michael Dickinson, Michael Crump, Kathryn Humphrey, Martin Barrett, Amitkumar Mehta, Franck Morschhauser, Chun Wu, Martin Hutchings, Anesh Panchal
Publikováno v:
Blood. 138:2479-2479
Background: Over a third of pts with 1L DLBCL do not respond to, or relapse after, rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP; [Sarkozy and Sehn. Ann Lymphoma 2019]). Despite recent advances, pts with R/R NHL have li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d93449c7322406161ac50962ded27638
https://doi.org/10.1182/blood-2021-147780
https://doi.org/10.1182/blood-2021-147780